CBL Patras S.A.

Founded in 1990 by Prof. Kleomenis Barlos, CBL (Chemical and Biopharmaceutical Laboratories of Patras S.A.) is a high-technology peptide manufacturer located in the Industrial Area of Patras, Greece. The company has been a global leader in the field of pharmaceutical products for the past twenty years, focusing on research for new products and improving production methods of chemical, bio-chemical, pharmaceutical, and natural products.

CBL's range of products includes peptide starting materials, peptide intermediates, and industrial and commercial-scale manufacturing of proprietary and generic GMP and non-GMP peptides. As one of the leading suppliers in the industry, the company invests heavily in innovation and has successfully transitioned from laboratory to industrial scale through significant co-operations, maintaining full automation and adherence to GMP compliance.

Notably, CBL achieves production through chemical reactions conducted in specially designed and fully equipped reactors within closed systems, with the retrieval of solvents upon completion of the process. The products of these reactions are isolated using state-of-the-art technology closed systems and packed in containers as liquids or powder after drying or clarification, demonstrating the company's commitment to technological advancement and quality production processes.